Despite the benefits of blood glucose-lowering medications, including oral agents and exogenous insulin, in controlling the progression of type 2 diabetes and its complications, the safety of these drugs has been recently debated due to their side effects [6]. Here, INS is linked to type 2 diabetes mellitus.